Oral direct-acting antiviral therapy for hepatitis C virus infection in X-linked agammaglobulinemia
Publication date: March 2019Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 7, Issue 3Author(s): Hermann M. Wolf, Martha M. Eibl, Christian J. Müller
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Antiviral Therapy | Hepatitis | Hepatitis C | X-Linked Agammaglobulinemia (XLA)